VYCO — VYCOR MEDICAL INC

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 1424768 ·
Last close
$0.04
Market Cap
$1.47M
52W High
$0.20
52W Low
$0.02
ADV30
18,067
Next earnings
—
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 418,264 344,445 6,851 -22,288 813,174 158,907 5,064,398
Mar 2026 458,540 375,153 45,808 20,108 854,071 173,634 5,083,027
Dec 2025 416,877 335,370 -36,525 -62,686 830,420 86,982 4,917,299
Sep 2025 513,792 451,932 32,085 4,936 941,195 64,230 4,965,388

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$59,853
Investing CF
$876
Financing CF
$-3,073
CapEx
$-1,606
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-33,813,221
Inventory
$190,508
Receivables
$202,447
ST Investments
—
EBIT TTM
$47,579
Pretax Income TTM
$-56,403
Interest Exp TTM
$103,982
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,807,473
EBITDA
$110,312
Free Cash Flow
$387,267
Enterprise Value
$3,041,497
Total Cash
$158,907
Total Debt
$957,725
Shares Out
33,372,796
Trailing EPS
$0.00
Book Value
$-0.12
ROE
—
ROA
3.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,863,400 33,900 -72,426 830,420 4,917,299 -4,086,879 -13,471
Dec 2024 1,589,324 -9,145 -107,200 998,117 4,688,200 -3,690,083 60,110
Dec 2023 1,460,604 40,191 -69,691 992,298 4,317,774 -3,325,476 29,430
Dec 2022 1,222,989 -306,514 -404,917 860,178 3,801,049 -2,940,871 -217,016

TTM Snapshot

Revenues TTM
$1,807,473
NetIncome TTM
$-59,930
OpCashFlow TTM
—
Assets (Latest)
$813,174
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
ESMC ESCALON MEDICAL CORP $1.40M $0.19 —
CUPR Cuprina Holdings (Cayman) LTD $1.56M $1.69 —
VVOS Vivos Therapeutics, Inc. $1.60M $0.08 —
NXL Nexalin Technology, Inc. $1.85M $1.50 —
BBLG Bone Biologics Corp $1.05M $0.31 —

News headlines (Yahoo Finance, 1h cache)

Vycor Medical Releases Financial Results for the Three and Nine Months Ended September 30, 2026
2026-11-13 16:36 · Yahoo
Vycor Medical Releases Financial Results for the Three and Six Months Ended June 30, 2026
2026-08-14 20:14 · Yahoo
Vycor Medical Releases Financial Results for the Year Ended December 31, 2025
2026-03-31 18:53 · Yahoo
Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
2026-05-15 19:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.